Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p3165 has 128 genes in the original annotation. Currently, there are 93 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
6387	CXCL12	IRH \| PBSF \| SCYB12 \| SDF1 \| TLSF \| TPAR1	C-X-C motif chemokine ligand 12	10q11.1
4153	MBL2	COLEC1 \| HSMBPC \| MBL \| MBL2D \| MBP \| MBP-C \| MBP1 \| MBPD	mannose binding lectin 2	10q11.2
54541	DDIT4	Dig2 \| REDD-1 \| REDD1	DNA damage inducible transcript 4	10q22.1
59	ACTA2	AAT6 \| ACTSA \| MYMY5	actin, alpha 2, smooth muscle, aorta	10q23.3
150	ADRA2A	ADRA2 \| ADRA2R \| ADRAR \| ALPHA2AAR \| ZNF32	adrenoceptor alpha 2A	10q25.2
6934	TCF7L2	TCF-4 \| TCF4	transcription factor 7 like 2	10q25.3
133	ADM	AM \| PAMP	adrenomedullin	11p15.4
7465	WEE1	WEE1A \| WEE1hu	WEE1 G2 checkpoint kinase	11p15.4
3481	IGF2	C11orf43 \| GRDF \| IGF-II \| PP9974	insulin like growth factor 2	11p15.5
7106	TSPAN4	NAG-2 \| NAG2 \| TETRASPAN \| TM4SF7 \| TSPAN-4	tetraspanin 4	11p15.5
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
4312	MMP1	CLG \| CLGN	matrix metallopeptidase 1	11q22.3
6876	TAGLN	SM22 \| SMCC \| TAGLN1 \| WS3-10	transgelin	11q23.2
715	C1R	-	complement C1r subcomponent	12p13
6445	SGCG	35DAG \| A4 \| DAGA4 \| DMDA \| DMDA1 \| LGMD2C \| MAM \| SCARMD2 \| SCG3 \| gamma-SG	sarcoglycan gamma	13q12
2155	F7	SPCA	coagulation factor VII	13q34
652	BMP4	BMP2B \| BMP2B1 \| MCOPS6 \| OFC11 \| ZYME	bone morphogenetic protein 4	14q22-q23
677	ZFP36L1	BRF1 \| Berg36 \| ERF-1 \| ERF1 \| RNF162B \| TIS11B \| cMG1	ZFP36 ring finger protein-like 1	14q24.1
7057	THBS1	THBS \| THBS-1 \| TSP \| TSP-1 \| TSP1	thrombospondin 1	15q15
7158	TP53BP1	53BP1 \| TDRD30 \| TP53 \| p202 \| p53BP1	tumor protein p53 binding protein 1	15q15-q21
2252	FGF7	HBGF-7 \| KGF	fibroblast growth factor 7	15q21.2
7026	NR2F2	ARP1 \| CHTD4 \| COUPTFB \| COUPTFII \| NF-E3 \| NR2F1 \| SVP40 \| TFCOUP2	nuclear receptor subfamily 2 group F member 2	15q26
3480	IGF1R	CD221 \| IGFIR \| IGFR \| JTK13	insulin like growth factor 1 receptor	15q26.3
1009	CDH11	CAD11 \| CDHOB \| OB \| OSF-4	cadherin 11	16q21
16	AARS	CMT2N \| EIEE29	alanyl-tRNA synthetase	16q22
5048	PAFAH1B1	LIS1 \| LIS2 \| MDCR \| MDS \| PAFAH	platelet activating factor acetylhydrolase 1b regulatory subunit 1	17p13.3
71	ACTG1	ACT \| ACTG \| BRWS2 \| DFNA20 \| DFNA26 \| HEL-176	actin gamma 1	17q25
5831	PYCR1	ARCL2B \| ARCL3B \| P5C \| P5CR \| PIG45 \| PP222 \| PRO3 \| PYCR	pyrroline-5-carboxylate reductase 1	17q25.3
25925	ZNF521	EHZF \| Evi3	zinc finger protein 521	18q11.2
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
3949	LDLR	FH \| FHC \| LDLCQ2	low density lipoprotein receptor	19p13.2
4782	NFIC	CTF \| CTF5 \| NF-I \| NFI	nuclear factor I/C (CCAAT-binding transcription factor)	19p13.3
4145	MATK	CHK \| CTK \| HHYLTK \| HYL \| HYLTK \| Lsk	megakaryocyte-associated tyrosine kinase	19p13.3
1675	CFD	ADIPSIN \| ADN \| DF \| PFD	complement factor D (adipsin)	19p13.3
348	APOE	AD2 \| APO-E \| LDLCQ5 \| LPG	apolipoprotein E	19q13.2
2512	FTL	LFTD \| NBIA3	ferritin, light polypeptide	19q13.33
7137	TNNI3	CMD1FF \| CMD2A \| CMH7 \| RCM1 \| TNNC1 \| cTnI	troponin I3, cardiac type	19q13.4
7049	TGFBR3	BGCAN \| betaglycan	transforming growth factor beta receptor III	1p33-p32
5872	RAB13	GIG4	RAB13, member RAS oncogene family	1q21.2
4000	LMNA	CDCD1 \| CDDC \| CMD1A \| CMT2B1 \| EMD2 \| FPL \| FPLD \| FPLD2 \| HGPS \| IDC \| LDP1 \| LFP \| LGMD1B \| LMN1 \| LMNC \| LMNL1 \| PRO1	lamin A/C	1q22
4921	DDR2	MIG20a \| NTRKR3 \| TKT \| TYRO10	discoidin domain receptor tyrosine kinase 2	1q23.3
5740	PTGIS	CYP8 \| CYP8A1 \| PGIS \| PTGI	prostaglandin I2 (prostacyclin) synthase	20q13.13
6453	ITSN1	ITSN \| SH3D1A \| SH3P17	intersectin 1	21q22.1-q22.2
1292	COL6A2	BTHLM1 \| PP3610 \| UCMD1	collagen type VI alpha 2	21q22.3
861	RUNX1	AML1 \| AML1-EVI-1 \| AMLCR1 \| CBF2alpha \| CBFA2 \| EVI-1 \| PEBP2aB \| PEBP2alpha	runt related transcription factor 1	21q22.3
7078	TIMP3	HSMRK222 \| K222 \| K222TA2 \| SFD	TIMP metallopeptidase inhibitor 3	22q12.3
4627	MYH9	BDPLT6 \| DFNA17 \| EPSTS \| FTNS \| MHA \| NMHC-II-A \| NMMHC-IIA \| NMMHCA	myosin, heavy chain 9, non-muscle	22q13.1
2202	EFEMP1	DHRD \| DRAD \| FBLN3 \| FBNL \| FIBL-3 \| MLVT \| MTLV \| S1-5	EGF containing fibulin-like extracellular matrix protein 1	2p16
1545	CYP1B1	CP1B \| CYPIB1 \| GLC3A \| P4501B1	cytochrome P450 family 1 subfamily B member 1	2p22.2
64682	ANAPC1	APC1 \| MCPR \| TSG24	anaphase promoting complex subunit 1	2q12.1
3176	HNMT	HMT \| HNMT-S1 \| HNMT-S2 \| MRT51	histamine N-methyltransferase	2q22.1
92	ACVR2A	ACTRII \| ACVR2	activin A receptor type 2A	2q22.3
5937	RBMS1	C2orf12 \| HCC-4 \| MSSP \| MSSP-1 \| MSSP-2 \| MSSP-3 \| SCR2 \| YC1	RNA binding motif, single stranded interacting protein 1	2q24.2
1281	COL3A1	EDS4A	collagen type III alpha 1	2q31
3485	IGFBP2	IBP2 \| IGF-BP53	insulin like growth factor binding protein 2	2q35
4286	MITF	CMM8 \| MI \| WS2 \| WS2A \| bHLHe32	microphthalmia-associated transcription factor	3p13
3913	LAMB2	LAMS \| NPHS5	laminin subunit beta 2	3p21
2876	GPX1	GPXD \| GSHPX1	glutathione peroxidase 1	3p21.3
7375	USP4	UNP \| Unph	ubiquitin specific peptidase 4 (proto-oncogene)	3p21.3
5156	PDGFRA	CD140A \| GAS9 \| PDGFR-2 \| PDGFR2 \| RHEPDGFRA	platelet derived growth factor receptor alpha	4q12
5783	PTPN13	FAP-1 \| PNP1 \| PTP-BAS \| PTP-BL \| PTP1E \| PTPL1 \| PTPLE \| hPTP1E	protein tyrosine phosphatase, non-receptor type 13	4q21.3
125	ADH1B	ADH2 \| HEL-S-117	alcohol dehydrogenase 1B (class I), beta polypeptide	4q23
152503	SH3D19	EBP \| EVE1 \| Kryn \| SH3P19	SH3 domain containing 19	4q31.3
10468	FST	FS	follistatin	5q11.2
1393	CRHBP	CRF-BP \| CRFBP	corticotropin releasing hormone binding protein	5q13.3
1462	VCAN	CSPG2 \| ERVR \| GHAP \| PG-M \| WGN \| WGN1	versican	5q14.3
4015	LOX	-	lysyl oxidase	5q23.2
2908	NR3C1	GCCR \| GCR \| GCRST \| GR \| GRL	nuclear receptor subfamily 3 group C member 1	5q31.3
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
7020	TFAP2A	AP-2 \| AP-2alpha \| AP2TF \| BOFS \| TFAP2	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)	6p24
5269	SERPINB6	CAP \| DFNB91 \| MSTP057 \| PI-6 \| PI6 \| PTI \| SPI3	serpin peptidase inhibitor, clade B (ovalbumin), member 6	6p25
3910	LAMA4	CMD1JJ \| LAMA3 \| LAMA4*-1	laminin subunit alpha 4	6q21
4082	MARCKS	80K-L \| MACS \| PKCSL \| PRKCSL	myristoylated alanine rich protein kinase C substrate	6q22.2
3097	HIVEP2	HIV-EP2 \| MBP-2 \| MIBP1 \| SHN2 \| ZAS2 \| ZNF40B	human immunodeficiency virus type I enhancer binding protein 2	6q23-q24
7058	THBS2	TSP2	thrombospondin 2	6q27
3486	IGFBP3	BP-53 \| IBP3	insulin like growth factor binding protein 3	7p12.3
196	AHR	bHLHe76	aryl hydrocarbon receptor	7p15
84310	C7orf50	YCR016W	chromosome 7 open reading frame 50	7p22.3
2056	EPO	EP \| MVCD2	erythropoietin	7q22
1278	COL1A2	OI4	collagen type I alpha 2	7q22.1
5054	SERPINE1	PAI \| PAI-1 \| PAI1 \| PLANH1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1	7q22.1
1052	CEBPD	C/EBP-delta \| CELF \| CRP3 \| NF-IL6-beta	CCAAT/enhancer binding protein delta	8p11.2-p11.1
26986	PABPC1	PAB1 \| PABP \| PABP1 \| PABPC2 \| PABPL1	poly(A) binding protein, cytoplasmic 1	8q22.2-q23
7169	TPM2	AMCD1 \| DA1 \| DA2B \| HEL-S-273 \| NEM4 \| TMSB	tropomyosin 2 (beta)	9p13
48	ACO1	ACONS \| HEL60 \| IREB1 \| IREBP \| IREBP1 \| IRP1	aconitase 1	9p21.1
1306	COL15A1	-	collagen type XV alpha 1	9q21-q22
301	ANXA1	ANX1 \| LPC1	annexin A1	9q21.13
2619	GAS1	-	growth arrest specific 1	9q21.3-q22
25	ABL1	ABL \| JTK7 \| bcr/abl \| c-ABL \| c-ABL1 \| p150 \| v-abl	ABL proto-oncogene 1, non-receptor tyrosine kinase	9q34.1
2022	ENG	END \| HHT1 \| ORW1	endoglin	9q34.11
5900	RALGDS	RGDS \| RGF \| RalGEF	ral guanine nucleotide dissociation stimulator	9q34.3
367	AR	AIS \| AR8 \| DHTR \| HUMARA \| HYSP1 \| KD \| NR3C4 \| SBMA \| SMAX1 \| TFM	androgen receptor	Xq12
7105	TSPAN6	T245 \| TM4SF6 \| TSPAN-6	tetraspanin 6	Xq22